Kestra Advisory Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Sell
474
-611
-56% -$313K ﹤0.01% 2850
2025
Q4
$609K Buy
1,085
+332
+44% +$188K ﹤0.01% 2000
2025
Q3
$387K Sell
753
-28
-4% -$12.2K ﹤0.01% 2246
2025
Q2
$245K Buy
781
+3
+0.4% +$901 ﹤0.01% 2518
2025
Q1
$237K Sell
778
-1,531
-66% -$515K ﹤0.01% 2354
2024
Q4
$767K Buy
2,309
+218
+10% +$73.9K ﹤0.01% 1569
2024
Q3
$698K Buy
2,091
+1,164
+126% +$442K ﹤0.01% 1545
2024
Q2
$382K Buy
927
+161
+21% +$63.8K ﹤0.01% 1963
2024
Q1
$310K Buy
+766
New +$269K ﹤0.01% 1975

Other funds holding MEDP

Kestra Advisory Services's MEDP Position: Q1 2026 in Review

Kestra Advisory Services reduced its Medpace (MEDP) stake by 56% in Q1 2026, selling an estimated $313K and leaving 474 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #2850.

Kestra Advisory Services first reported a position in MEDP in Q1 2024 and has held it in 9 quarters since. The position peaked at $767K in Q4 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Kestra Advisory Services held 474 shares of Medpace worth $228K as of Q1 2026.
  • Kestra Advisory Services sold 611 Medpace shares in Q1 2026, an estimated $313K.
  • Medpace made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #2850 holding.
  • Kestra Advisory Services first reported a position in Medpace in Q1 2024 and has held it in 9 quarters since.
  • Kestra Advisory Services's Medpace position peaked at $767K in Q4 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.